Report Detail

Medical Industry Global Perineural Therapy Market Growth (Status and Outlook) 2022-2028

  • RnM4398793
  • |
  • 15 March, 2022
  • |
  • Global
  • |
  • 114 Pages
  • |
  • LPI(LP Information)
  • |
  • Medical Industry

As the global economy mends, the 2021 growth of Perineural Therapy will have significant change from previous year. According to our (LP Information) latest study, the global Perineural Therapy market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Perineural Therapy market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Perineural Therapy market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Perineural Therapy market, reaching US$ million by the year 2028. As for the Europe Perineural Therapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Perineural Therapy players cover Medtronic, Boston Scientific Corporation, Abbott Laboratories, and AxoGen, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Perineural Therapy market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Internal Neurostimulation
External Neurostimulation

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Hospitals and Clinics
Ambulatory Surgical Centers
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Medtronic
Boston Scientific Corporation
Abbott Laboratories
AxoGen
Baxter International
LivaNova
Integra LifeSciences
Polyganics
NeuroPace
Soterix Medical
Nevro
Synapse Biomedical
Aleva Neurotherapeutics
Collagen Matrix
KeriMedical
BioWave Corporation
NeuroSigma
tVNS Technologies GmbH
GiMer Medical


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Perineural Therapy Market Size 2017-2028
    • 2.1.2 Perineural Therapy Market Size CAGR by Region 2017 VS 2022 VS 2028
  • 2.2 Perineural Therapy Segment by Type
    • 2.2.1 Internal Neurostimulation
    • 2.2.2 External Neurostimulation
  • 2.3 Perineural Therapy Market Size by Type
    • 2.3.1 Perineural Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028)
    • 2.3.2 Global Perineural Therapy Market Size Market Share by Type (2017-2022)
  • 2.4 Perineural Therapy Segment by Application
    • 2.4.1 Hospitals and Clinics
    • 2.4.2 Ambulatory Surgical Centers
    • 2.4.3 Others
  • 2.5 Perineural Therapy Market Size by Application
    • 2.5.1 Perineural Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028)
    • 2.5.2 Global Perineural Therapy Market Size Market Share by Application (2017-2022)

3 Perineural Therapy Market Size by Player

  • 3.1 Perineural Therapy Market Size Market Share by Players
    • 3.1.1 Global Perineural Therapy Revenue by Players (2020-2022)
    • 3.1.2 Global Perineural Therapy Revenue Market Share by Players (2020-2022)
  • 3.2 Global Perineural Therapy Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Perineural Therapy by Regions

  • 4.1 Perineural Therapy Market Size by Regions (2017-2022)
  • 4.2 Americas Perineural Therapy Market Size Growth (2017-2022)
  • 4.3 APAC Perineural Therapy Market Size Growth (2017-2022)
  • 4.4 Europe Perineural Therapy Market Size Growth (2017-2022)
  • 4.5 Middle East & Africa Perineural Therapy Market Size Growth (2017-2022)

5 Americas

  • 5.1 Americas Perineural Therapy Market Size by Country (2017-2022)
  • 5.2 Americas Perineural Therapy Market Size by Type (2017-2022)
  • 5.3 Americas Perineural Therapy Market Size by Application (2017-2022)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Perineural Therapy Market Size by Region (2017-2022)
  • 6.2 APAC Perineural Therapy Market Size by Type (2017-2022)
  • 6.3 APAC Perineural Therapy Market Size by Application (2017-2022)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Perineural Therapy by Country (2017-2022)
  • 7.2 Europe Perineural Therapy Market Size by Type (2017-2022)
  • 7.3 Europe Perineural Therapy Market Size by Application (2017-2022)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Perineural Therapy by Region (2017-2022)
  • 8.2 Middle East & Africa Perineural Therapy Market Size by Type (2017-2022)
  • 8.3 Middle East & Africa Perineural Therapy Market Size by Application (2017-2022)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Perineural Therapy Market Forecast

  • 10.1 Global Perineural Therapy Forecast by Regions (2023-2028)
    • 10.1.1 Global Perineural Therapy Forecast by Regions (2023-2028)
    • 10.1.2 Americas Perineural Therapy Forecast
    • 10.1.3 APAC Perineural Therapy Forecast
    • 10.1.4 Europe Perineural Therapy Forecast
    • 10.1.5 Middle East & Africa Perineural Therapy Forecast
  • 10.2 Americas Perineural Therapy Forecast by Country (2023-2028)
    • 10.2.1 United States Perineural Therapy Market Forecast
    • 10.2.2 Canada Perineural Therapy Market Forecast
    • 10.2.3 Mexico Perineural Therapy Market Forecast
    • 10.2.4 Brazil Perineural Therapy Market Forecast
  • 10.3 APAC Perineural Therapy Forecast by Region (2023-2028)
    • 10.3.1 China Perineural Therapy Market Forecast
    • 10.3.2 Japan Perineural Therapy Market Forecast
    • 10.3.3 Korea Perineural Therapy Market Forecast
    • 10.3.4 Southeast Asia Perineural Therapy Market Forecast
    • 10.3.5 India Perineural Therapy Market Forecast
    • 10.3.6 Australia Perineural Therapy Market Forecast
  • 10.4 Europe Perineural Therapy Forecast by Country (2023-2028)
    • 10.4.1 Germany Perineural Therapy Market Forecast
    • 10.4.2 France Perineural Therapy Market Forecast
    • 10.4.3 UK Perineural Therapy Market Forecast
    • 10.4.4 Italy Perineural Therapy Market Forecast
    • 10.4.5 Russia Perineural Therapy Market Forecast
  • 10.5 Middle East & Africa Perineural Therapy Forecast by Region (2023-2028)
    • 10.5.1 Egypt Perineural Therapy Market Forecast
    • 10.5.2 South Africa Perineural Therapy Market Forecast
    • 10.5.3 Israel Perineural Therapy Market Forecast
    • 10.5.4 Turkey Perineural Therapy Market Forecast
    • 10.5.5 GCC Countries Perineural Therapy Market Forecast
  • 10.6 Global Perineural Therapy Forecast by Type (2023-2028)
  • 10.7 Global Perineural Therapy Forecast by Application (2023-2028)

11 Key Players Analysis

  • 11.1 Medtronic
    • 11.1.1 Medtronic Company Information
    • 11.1.2 Medtronic Perineural Therapy Product Offered
    • 11.1.3 Medtronic Perineural Therapy Revenue, Gross Margin and Market Share (2020-2022)
    • 11.1.4 Medtronic Main Business Overview
    • 11.1.5 Medtronic Latest Developments
  • 11.2 Boston Scientific Corporation
    • 11.2.1 Boston Scientific Corporation Company Information
    • 11.2.2 Boston Scientific Corporation Perineural Therapy Product Offered
    • 11.2.3 Boston Scientific Corporation Perineural Therapy Revenue, Gross Margin and Market Share (2020-2022)
    • 11.2.4 Boston Scientific Corporation Main Business Overview
    • 11.2.5 Boston Scientific Corporation Latest Developments
  • 11.3 Abbott Laboratories
    • 11.3.1 Abbott Laboratories Company Information
    • 11.3.2 Abbott Laboratories Perineural Therapy Product Offered
    • 11.3.3 Abbott Laboratories Perineural Therapy Revenue, Gross Margin and Market Share (2020-2022)
    • 11.3.4 Abbott Laboratories Main Business Overview
    • 11.3.5 Abbott Laboratories Latest Developments
  • 11.4 AxoGen
    • 11.4.1 AxoGen Company Information
    • 11.4.2 AxoGen Perineural Therapy Product Offered
    • 11.4.3 AxoGen Perineural Therapy Revenue, Gross Margin and Market Share (2020-2022)
    • 11.4.4 AxoGen Main Business Overview
    • 11.4.5 AxoGen Latest Developments
  • 11.5 Baxter International
    • 11.5.1 Baxter International Company Information
    • 11.5.2 Baxter International Perineural Therapy Product Offered
    • 11.5.3 Baxter International Perineural Therapy Revenue, Gross Margin and Market Share (2020-2022)
    • 11.5.4 Baxter International Main Business Overview
    • 11.5.5 Baxter International Latest Developments
  • 11.6 LivaNova
    • 11.6.1 LivaNova Company Information
    • 11.6.2 LivaNova Perineural Therapy Product Offered
    • 11.6.3 LivaNova Perineural Therapy Revenue, Gross Margin and Market Share (2020-2022)
    • 11.6.4 LivaNova Main Business Overview
    • 11.6.5 LivaNova Latest Developments
  • 11.7 Integra LifeSciences
    • 11.7.1 Integra LifeSciences Company Information
    • 11.7.2 Integra LifeSciences Perineural Therapy Product Offered
    • 11.7.3 Integra LifeSciences Perineural Therapy Revenue, Gross Margin and Market Share (2020-2022)
    • 11.7.4 Integra LifeSciences Main Business Overview
    • 11.7.5 Integra LifeSciences Latest Developments
  • 11.8 Polyganics
    • 11.8.1 Polyganics Company Information
    • 11.8.2 Polyganics Perineural Therapy Product Offered
    • 11.8.3 Polyganics Perineural Therapy Revenue, Gross Margin and Market Share (2020-2022)
    • 11.8.4 Polyganics Main Business Overview
    • 11.8.5 Polyganics Latest Developments
  • 11.9 NeuroPace
    • 11.9.1 NeuroPace Company Information
    • 11.9.2 NeuroPace Perineural Therapy Product Offered
    • 11.9.3 NeuroPace Perineural Therapy Revenue, Gross Margin and Market Share (2020-2022)
    • 11.9.4 NeuroPace Main Business Overview
    • 11.9.5 NeuroPace Latest Developments
  • 11.10 Soterix Medical
    • 11.10.1 Soterix Medical Company Information
    • 11.10.2 Soterix Medical Perineural Therapy Product Offered
    • 11.10.3 Soterix Medical Perineural Therapy Revenue, Gross Margin and Market Share (2020-2022)
    • 11.10.4 Soterix Medical Main Business Overview
    • 11.10.5 Soterix Medical Latest Developments
  • 11.11 Nevro
    • 11.11.1 Nevro Company Information
    • 11.11.2 Nevro Perineural Therapy Product Offered
    • 11.11.3 Nevro Perineural Therapy Revenue, Gross Margin and Market Share (2020-2022)
    • 11.11.4 Nevro Main Business Overview
    • 11.11.5 Nevro Latest Developments
  • 11.12 Synapse Biomedical
    • 11.12.1 Synapse Biomedical Company Information
    • 11.12.2 Synapse Biomedical Perineural Therapy Product Offered
    • 11.12.3 Synapse Biomedical Perineural Therapy Revenue, Gross Margin and Market Share (2020-2022)
    • 11.12.4 Synapse Biomedical Main Business Overview
    • 11.12.5 Synapse Biomedical Latest Developments
  • 11.13 Aleva Neurotherapeutics
    • 11.13.1 Aleva Neurotherapeutics Company Information
    • 11.13.2 Aleva Neurotherapeutics Perineural Therapy Product Offered
    • 11.13.3 Aleva Neurotherapeutics Perineural Therapy Revenue, Gross Margin and Market Share (2020-2022)
    • 11.13.4 Aleva Neurotherapeutics Main Business Overview
    • 11.13.5 Aleva Neurotherapeutics Latest Developments
  • 11.14 Collagen Matrix
    • 11.14.1 Collagen Matrix Company Information
    • 11.14.2 Collagen Matrix Perineural Therapy Product Offered
    • 11.14.3 Collagen Matrix Perineural Therapy Revenue, Gross Margin and Market Share (2020-2022)
    • 11.14.4 Collagen Matrix Main Business Overview
    • 11.14.5 Collagen Matrix Latest Developments
  • 11.15 KeriMedical
    • 11.15.1 KeriMedical Company Information
    • 11.15.2 KeriMedical Perineural Therapy Product Offered
    • 11.15.3 KeriMedical Perineural Therapy Revenue, Gross Margin and Market Share (2020-2022)
    • 11.15.4 KeriMedical Main Business Overview
    • 11.15.5 KeriMedical Latest Developments
  • 11.16 BioWave Corporation
    • 11.16.1 BioWave Corporation Company Information
    • 11.16.2 BioWave Corporation Perineural Therapy Product Offered
    • 11.16.3 BioWave Corporation Perineural Therapy Revenue, Gross Margin and Market Share (2020-2022)
    • 11.16.4 BioWave Corporation Main Business Overview
    • 11.16.5 BioWave Corporation Latest Developments
  • 11.17 NeuroSigma
    • 11.17.1 NeuroSigma Company Information
    • 11.17.2 NeuroSigma Perineural Therapy Product Offered
    • 11.17.3 NeuroSigma Perineural Therapy Revenue, Gross Margin and Market Share (2020-2022)
    • 11.17.4 NeuroSigma Main Business Overview
    • 11.17.5 NeuroSigma Latest Developments
  • 11.18 tVNS Technologies GmbH
    • 11.18.1 tVNS Technologies GmbH Company Information
    • 11.18.2 tVNS Technologies GmbH Perineural Therapy Product Offered
    • 11.18.3 tVNS Technologies GmbH Perineural Therapy Revenue, Gross Margin and Market Share (2020-2022)
    • 11.18.4 tVNS Technologies GmbH Main Business Overview
    • 11.18.5 tVNS Technologies GmbH Latest Developments
  • 11.19 GiMer Medical
    • 11.19.1 GiMer Medical Company Information
    • 11.19.2 GiMer Medical Perineural Therapy Product Offered
    • 11.19.3 GiMer Medical Perineural Therapy Revenue, Gross Margin and Market Share (2020-2022)
    • 11.19.4 GiMer Medical Main Business Overview
    • 11.19.5 GiMer Medical Latest Developments

12 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Perineural Therapy. Industry analysis & Market Report on Perineural Therapy is a syndicated market report, published as Global Perineural Therapy Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Perineural Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
2,917.02
5,834.04
3,400.14
6,800.28
559,723.80
1,119,447.60
305,317.20
610,634.40
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report